Close

More on ROIV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-40.0% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (6/26/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Roivant Sciences (NQ:ROIV)
Delayed: 10.88 -0.02 (0.18%)
Prev. Close $10.90  
Open$10.78 
52 Wk High$ 
52 Wk Low$ 
Day High$10.91 
Day Low$10.51 
P/E N/A  
EPS$ 
Volume3,719,630 

Friends, Peers and Foes (?): IMVT, PFE, PGTI, ROIVW, ARGX (more...)

Apr 25, 2024 08:00 AM Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis
Apr 24, 2024 09:12 PM Form 4 Roivant Sciences Ltd. For: Apr 22 Filed by: Pulik Richard
Apr 24, 2024 09:12 PM Form 4 Roivant Sciences Ltd. For: Apr 22 Filed by: Kumar Rakhi
Apr 23, 2024 09:01 PM Form 4 Roivant Sciences Ltd. For: Apr 20 Filed by: Pulik Richard
Apr 23, 2024 09:01 PM Form 4 Roivant Sciences Ltd. For: Apr 20 Filed by: Kumar Rakhi
Apr 23, 2024 09:01 PM Form 4 Roivant Sciences Ltd. For: Apr 20 Filed by: Gline Matthew
Apr 23, 2024 09:01 PM Form 4 Roivant Sciences Ltd. For: Apr 20 Filed by: Venker Eric
Apr 12, 2024 06:01 PM Form 3 Roivant Sciences Ltd. For: Apr 02 Filed by: Ramaswamy Vivek
Apr 3, 2024 06:43 AM Roivant Sciences (ROIV) PT Raised to $18 at H.C. Wainwright, 'brepocitinib has blockbuster potential'
Apr 3, 2024 02:18 AM Roivant Sciences (ROIV) PT Raised to $15 at Deutsche Bank
View All Articles

Entities mentioned with ROIV

View All Entities